Literature DB >> 15988245

Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints.

Gary Borodic1, Mary Bartley, William Slattery, Michael Glasscock, Eric Johnson, Carl Malazio, Michael Goodnough, Martin Acquadro, Michael McKenna.   

Abstract

BACKGROUND: Aberrant facial nerve regeneration syndrome is systematically studied by constructing a subjective questionnaire organized into pertinent domains (impairment of quality of life, social interactions, perception of self-appearance, visual function, and perception of problem severity) and by physical assessment of degree of involuntary palpebral fissure closure during routine facial movements using videotaping and a physicians' grading scale.
METHODS: The videotape measurements of corneal light reflex to upper lid margin distance and vertical palpebral distance were made during adynamic and active facial expression. Thirty-six patients were studied (six in an open-label pilot study design and 30 in a multicenter, double-blind, placebo-controlled trial). Botulinum toxin type A injections consistently suppressed the degree of involuntary eyelid movement associated with smiling, chewing, and puckering by each measurement and in both study designs.
RESULTS: In all subjective morbidity domains, improvement was demonstrated in the double-blind study design (quality of life, p < 0.05; social interaction, p < 0.001; personal appearance, p < 0.001; peripheral visual impairment, p < 0.01; and perception of severity, p < 0.05). Correlation between degrees of physical impairment was significant but low comparing degree of subjective impairment to direct videotaped measurements. Correlation was more significant comparing subjective scores to the physicians' grading scale assessment of degree of physical impairment.
CONCLUSIONS: Impairment in quality of life, social interactions, and self-assessment of appearance closely reflected the nature of the morbidity associated with palpebral fissure asymmetry associated with aberrant facial nerve regeneration. The physicians' grading scale best reflected subjective morbidity over direct videotaped measurements.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988245     DOI: 10.1097/01.prs.0000169689.27829.c4

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  11 in total

1.  [Botulinum toxin for ocular complications after facial palsy].

Authors:  E Torres Suárez
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

2.  A Novel Long-term Therapy of Facial Synkinesis with Botulinum Neurotoxins Type A and Fillers.

Authors:  Adam Wiener; Khasha Touloei; Bradley P Glick
Journal:  J Clin Aesthet Dermatol       Date:  2011-03

3.  Validation of a new photogrammetric technique to monitor the treatment effect of Botulinum toxin in synkinesis.

Authors:  N T Mabvuure; M-J Hallam; V Venables; C Nduka
Journal:  Eye (Lond)       Date:  2013-05-17       Impact factor: 3.775

4.  Too much or too little? A systematic review of postparetic synkinesis treatment.

Authors:  Jodi B Lapidus; Johnny Chuieng-Yi Lu; Katherine B Santosa; Lauren H Yaeger; Carolyn Stoll; Graham A Colditz; Alison Snyder-Warwick
Journal:  J Plast Reconstr Aesthet Surg       Date:  2019-10-11       Impact factor: 2.740

5.  Postparalysis facial synkinesis: clinical classification and surgical strategies.

Authors:  David Chwei-Chin Chuang; Tommy Nai-Jen Chang; Johnny Chuieng-Yi Lu
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-04-07

6.  Hypoglossal-facial nerve reconstruction using a Y-tube-conduit reduces aberrant synkinetic movements of the orbicularis oculi and vibrissal muscles in rats.

Authors:  Yasemin Kaya; Umut Ozsoy; Murat Turhan; Doychin N Angelov; Levent Sarikcioglu
Journal:  Biomed Res Int       Date:  2014-12-09       Impact factor: 3.411

7.  Quality of life assessment in facial palsy: validation of the Dutch Facial Clinimetric Evaluation Scale.

Authors:  Ingrid J Kleiss; Carien H G Beurskens; Peep F M Stalmeier; Koen J A O Ingels; Henri A M Marres
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-28       Impact factor: 2.503

8.  Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.

Authors:  Justin R Shinn; Nkechi N Nwabueze; Liping Du; Priyesh N Patel; Kevin K Motamedi; Cathey Norton; William R Ries; Scott J Stephan
Journal:  JAMA Facial Plast Surg       Date:  2019-05-01       Impact factor: 4.611

9.  Botulinum Toxin Therapy versus Anterior Belly of Digastric Transfer in the Management of Marginal Mandibular Branch of the Facial Nerve Palsy: A Patient Satisfaction Survey.

Authors:  Daniel P Butler; Jo I Leckenby; Ben H Miranda; Adriaan O Grobbelaar
Journal:  Arch Plast Surg       Date:  2015-11-16

10.  Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.

Authors:  Priyesh N Patel; Scott R Owen; Cathey P Norton; Brandon T Emerson; Andrea B Bronaugh; William R Ries; Scott J Stephan
Journal:  JAMA Facial Plast Surg       Date:  2018-05-01       Impact factor: 4.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.